To the Editor:

States hoping to lower drug costs for their citizens and looking to Canada for less expensive drugs are onto something.

For example: Epi-pen (used for allergic reactions): Can: $293; US $638. (New generic may be lower) Celebrex (used to alleviate arthritic pain): Can: $257; US: $1126. Crestor (against elevated cholesterol): Can: $201; US: $779. Synthroid (a 46-year-old drug to treat thyroid inadequacy): Can: $35; US: $109. Januvia (used to lower blood sugar); Can: $369; US: $1,126. Abilify (treatment for certain mental conditions): Can: $546; US: $2852.

Considering the income of various CEOs of the drug companies is also informative. Pfizer Pharmaceuticals (maker of Epi-pen, Celebrex): $27 million. Astra Zeneca (Crestor and Nexium — treats heartburn): $15.5 million. Abbott Labs (Synthroid): $15.6 million. Merck (Januvia — lowers blood sugar): $17 million. GlaxoSmithKline (Advair-Diskus, a drug to treat asthma): $1.2 million for the new CEO.

I thought that Trump promised to lower drug prices. His efforts seem not to be working.

Ben Liles

Salado

(1) comment

tomintexas

There is a giant step between what the U.S. should do and what it does or allows to be done with respect to its citizens welfare. In the early years of the Bush 2 administration, there was a huge cost advantage in patients' and insurers' obtaining brand name prescriptions from Canada. Factors were Canada's favorably negotiated drug prices amplified by the U.S. dollar's favorable exchange rate. Bush's Federal Reserve destroyed the latter, and his FDA appointees complicated the former by seizing or causing to be seized patients' prescription orders. These efforts were accompanied by dramatic and widely circulated disinformation campaigns by the multinational drug manufacturing cartel and the FDA at their behest. (Citizens should understand that the FDA is absolutely subservient to the cartel - as are many or most members of Congress and the executive branch. These obligations gravitate down to state regulatory agencies as well.) Claims of counterfeit or substandard Canadian drugs were not then or now valid and never substantiated. In fact the majority of counterfeit drugs came from within the U.S., where the big money was. There is still a price advantage to Canadian sourced drugs, but there are others that are just as advantageous or even better - Israel, Australia, and New Zealand for starters. But don't get your hopes up - through the cartel/government revolving door the cartel is deeply entrenched in the U.S. government at all levels, and as long as they can spend a little of the huge amount of money they steal from U.S. citizens to buy elected officials and regulators, they will continue to do so. Unless there is a dramatic change in this, U.S. healthcare will continue to be the most expensive in the developed world - and one of the least effective.

Welcome to the discussion.

Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
PLEASE TURN OFF YOUR CAPS LOCK.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.